Ingrown Toenail (Onychocryptosis) Differential Diagnoses

1. Rauch C, Cherkaoui-Rbati M. Physics of nail conditions: why do ingrown nails always happen in the big toes?. Phys Biol. 2014 Oct 16. 11 (6):066004. [QxMD MEDLINE Link].

2. Ingrown toenails. Last updated May 2007. Familydoctor.org. Available at http://familydoctor.org/online/famdocen/home/common/skin/disorders/208.html.

3. Sauer GC. Manual of Skin Diseases. JB Lippincott; 1985.

4. Barker LR, Burton JR, Zieve PD. Principles of Ambulatory Medicine. 3rd ed. Williams & Wilkins; 1991.

5. Chabchoub I, Litaiem N. Ingrown Toenails. 2021 Jan. [QxMD MEDLINE Link]. [Full Text].

6. Ezekian B, Englum BR, Gilmore BF, Kim J, Leraas HJ, Rice HE. Onychocryptosis in the Pediatric Patient. Clin Pediatr (Phila). 2017 Feb. 56(2):109-114.

7. Ozdemir E, Bostanci S, Ekmekci P, Gurgey E. Chemical matricectomy with 10% sodium hydroxide for the treatment of ingrowing toenails. Dermatol Surg. 2004 Jan. 30(1):26-31. [QxMD MEDLINE Link].

8. Watabe A, Yamasaki K, Hashimoto A, Aiba S. Retrospective evaluation of conservative treatment for 140 ingrown toenails with a novel taping procedure. Acta Derm Venereol. 2015 Sep. 95 (7):822-5. [QxMD MEDLINE Link].

9. Tsunoda M, Tsunoda K. Patient-controlled taping for the treatment of ingrown toenails. Ann Fam Med. 2014 Nov-Dec. 12 (6):553-5. [QxMD MEDLINE Link].

10. Di Chiacchio N, Di Chiacchio NG. Best way to treat an ingrown toenail. Dermatol Clin. 2015 Apr. 33 (2):277-82. [QxMD MEDLINE Link].

11. Grover C, Khurana A, Bhattacharya SN, Sharma A. Controlled trial comparing the efficacy of 88% phenol versus 10% sodium hydroxide for chemical matricectomy in the management of ingrown toenail. Indian J Dermatol Venereol Leprol. 2015 Sep-Oct. 81 (5):472-7. [QxMD MEDLINE Link].

12. DeBrule MB. Operative treatment of ingrown toenail by nail fold resection without matricectomy. J Am Podiatr Med Assoc. 2015 Jul. 105 (4):295-301. [QxMD MEDLINE Link].

13. Kim M, Song IG, Kim HJ. Partial Removal of Nail Matrix in the Treatment of Ingrown Nails: Prospective Randomized Control Study Between Curettage and Electrocauterization. Int J Low Extrem Wounds. 2015 Jun. 14 (2):192-5. [QxMD MEDLINE Link].

14. Haneke E. Controversies in the treatment of ingrown nails. Dermatol Res Pract. 2012. 2012:783924. [QxMD MEDLINE Link].

15. Muriel-Sánchez JM, Becerro-de-Bengoa-Vallejo R, Montaño-Jiménez P, Coheña-Jiménez M. The Treatment of Ingrown Nail: Chemical Matricectomy With Phenol Versus Aesthetic Reconstruction. A Single Blinded Randomized Clinical Trial. J Clin Med. 2020 Mar 20. 9 (3):[QxMD MEDLINE Link].

16. Montesi S, Lazzarino AI, Galeone G, Palmieri R, Montesi M. The Recurrence of Onychocryptosis when Treated with Phenolization: Does Phenol Application Time Play a Role? A Follow-Up Study on 622 Procedures. Dermatology. 2019. 235 (4):323-326. [QxMD MEDLINE Link].

17. Ramesh S, Shenoi SD, Nayak SUK. Comparative Efficacy of 10% Sodium Hydroxide, 88% Phenol, and 90% Trichloroacetic Acid as Chemical Cauterants for Partial Matricectomy in the Management of Great Toe Nail Onychocryptosis. J Cutan Aesthet Surg. 2020 Oct-Dec. 13 (4):314-318. [QxMD MEDLINE Link].

18. Eekhof JAH, Van Wijk B, Knuistingh Neven A, van der Wouden JC. Interventions for ingrowing toenails. Cochrane Database of Systematic Reviews. 2012.

19. Bossers AM, Jansen IM, Eggink WF. Rational therapy for ingrown toenails. A prospective study. Acta Orthop Belg. 1992. 58(3):325-9. [QxMD MEDLINE Link].

20. Fulton GJ, O'Donohoe MK, Reynolds JV, Keane FB, Tanner WA. Wedge resection alone or combined with segmental phenolization for the treatment of ingrowing toenail. Br J Surg. 1994 Jul. 81(7):1074-5. [QxMD MEDLINE Link].

21. Wollina U. Modified Emmet's operation for ingrown nails using the Er:YAG laser. J Cosmet Laser Ther. 2004 May. 6(1):38-40. [QxMD MEDLINE Link].

22. Kimata Y, Uetake M, Tsukada S, Harii K. Follow-up study of patients treated for ingrown nails with the nail matrix phenolization method. Plast Reconstr Surg. 1995 Apr. 95(4):719-24. [QxMD MEDLINE Link].

23. Zaborszky Z, Fekete L, Tauzin F, Orgovan G. Treatment of ingrowing toenail with segmental chemical ablation. Acta Chir Hung. 1997. 36(1-4):398-400. [QxMD MEDLINE Link].

24. Mori H, Umeda T, Nishioka K, et al. Ingrown nails: a comparison of the nail matrix phenolization method with the elevation of the nail bed-periosteal flap procedure. J Dermatol. 1998 Jan. 25(1):1-4. [QxMD MEDLINE Link].

25. Giacalone VF. Phenol matricectomy in patients with diabetes. J Foot Ankle Surg. 1997 Jul-Aug. 36(4):264-7; discussion 328. [QxMD MEDLINE Link].

26. Gera SK, PG Zaini DKH, Wang S, et al. Ingrowing toenails in children and adolescents: is nail avulsion superior to nonoperative treatment?. Singapore Med J. 2019 Feb. 60 (2):94-96. [QxMD MEDLINE Link].

27. Romero-Pérez D, Betlloch-Mas I, Encabo-Durán B. Onychocryptosis: a long-term retrospective and comparative follow-up study of surgical and phenol chemical matricectomy in 520 procedures. Int J Dermatol. 2017 Feb. 56 (2):221-224. [QxMD MEDLINE Link].

28. Mayeaux EJ Jr, Carter C, Murphy TE. Ingrown Toenail Management. Am Fam Physician. 2019 Aug 1. 100 (3):158-164. [QxMD MEDLINE Link].

29. Stacey SK. A practical guide to the care of ingrown toenails. J Fam Pract. 2019 May. 68 (4):199-203. [QxMD MEDLINE Link].

30. Jakubowska M, Wcisło-Dziadecka D. Conservative management of a severe case of onychocryptosis at a podiatric clinic-A case report. J Cosmet Dermatol. 2021 May 13. [QxMD MEDLINE Link].

31. Sargin S, Gulcu A, Aslan A. Does the Type of Surgical Technique and the Use of Prophylactic Antibiotics Affect the Clinical Results in Symptomatic Ingrown Toenail Patients?. Int J Low Extrem Wounds. 2021 Sep 13. 15347346211043602. [QxMD MEDLINE Link].

Thomas E Benzoni, DO, MT(ASCP) Attending Staff, Department of Emergency Medicine, Methodist Medical Center; Medical Director, Iowa Disaster Medical Assistance Team, Iowa Department of Health (IA DMAT IDPH)

Thomas E Benzoni, DO, MT(ASCP) is a member of the following medical societies: American College of Emergency Physicians, Iowa Medical Society, American College of Osteopathic Emergency Physicians, American Osteopathic Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Trevor John Mills, MD, MPH Chief of Emergency Medicine, Veterans Affairs Northern California Health Care System; Professor of Emergency Medicine, Department of Emergency Medicine, University of California, Davis, School of Medicine

Trevor John Mills, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians

Disclosure: Nothing to disclose.

Theodore J Gaeta, DO, MPH, FACEP Clinical Associate Professor, Department of Emergency Medicine, Weill Cornell Medical College; Vice Chairman and Program Director of Emergency Medicine Residency Program, Department of Emergency Medicine, New York Methodist Hospital; Academic Chair, Adjunct Professor, Department of Emergency Medicine, St George's University School of Medicine

Theodore J Gaeta, DO, MPH, FACEP is a member of the following medical societies: American College of Emergency Physicians, New York Academy of Medicine, Society for Academic Emergency Medicine, Council of Residency Directors in Emergency Medicine, Clerkship Directors in Emergency Medicine, Alliance for Clinical Education

Disclosure: Nothing to disclose.

Tom Scaletta, MD President, Smart-ER (http://smart-er.net); Chair, Department of Emergency Medicine, Edward Hospital; Past-President, American Academy of Emergency Medicine

Tom Scaletta, MD is a member of the following medical societies: American Academy of Emergency Medicine

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article